Skip to main navigation Skip to search Skip to main content

Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data

  • Sang Gune K. Yoo*
  • , Grace S. Chung
  • , Bahendeka K. Silver
  • , Abla M. Sibai
  • , Albertino Damasceno
  • , Farshad Farzadfar
  • , Peter Rohloff
  • , Corine Houehanou
  • , Bolormaa Norov
  • , Khem B. Karki
  • , Mohammadreza Azangou-Khyavy
  • , Maja E. Marcus
  • , Krishna K. Aryal
  • , Luisa C. C. Brant
  • , Michaela Theilmann
  • , Renata Cifkova
  • , Nuno Lunet
  • , Mongal S. Gurung
  • , Joseph Kibachio Mwangi
  • , Joao Martins
  • Rosa Haghshenas, Lela Sturua, Sebastian Vollmer, Till Bärnighausen, Rifat Atun, Jeremy B. Sussman, Kavita Singh, Sahar Saeedi Moghaddam, David Guwatudde, Pascal Geldsetzer, Jennifer Manne-Goehler, Mark D. Huffman, Justine I. Davies, David Flood
*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

70 Downloads (Pure)
Original languageEnglish
Article number44
Number of pages6
JournalGlobal Heart
Volume19
Issue number1
DOIs
Publication statusPublished - 3 May 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • cardiovascular disease
  • prevention
  • aspirin
  • Non-communicable disease

Cite this